# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-033852
Filing Date
2025-11-07
Accepted
2025-11-07 16:01:15
Documents
92
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | nby20250930_10q.htm iXBRL | 10-Q | 2304373
2 | EXHIBIT 31.1 | ex_879570.htm | EX-31.1 | 7975
3 | EXHIBIT 31.2 | ex_879569.htm | EX-31.2 | 8219
4 | EXHIBIT 32.1 | ex_879568.htm | EX-32.1 | 3908
5 | EXHIBIT 32.2 | ex_879567.htm | EX-32.2 | 3893
| Complete submission text file | 0001437749-25-033852.txt |  | 12284023

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20250930.xsd | EX-101.SCH | 100756
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20250930_def.xml | EX-101.DEF | 734230
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20250930_lab.xml | EX-101.LAB | 534771
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20250930_pre.xml | EX-101.PRE | 777525
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20250930_cal.xml | EX-101.CAL | 41323
95 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20250930_10q_htm.xml | XML | 2384630

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 251462456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)